- Home
- Publications
- Publication Search
- Publication Details
Title
Glucocerebrosidase and its relevance to Parkinson disease
Authors
Keywords
Gaucher disease, <em class="EmphasisTypeItalic ">GBA1</em>, Parkinson disease, Glucocerebrosidase, α-Synuclein, Lysosome
Journal
Molecular Neurodegeneration
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-29
DOI
10.1186/s13024-019-0336-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
- (2019) Angelique di Domenico et al. Stem Cell Reports
- Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
- (2019) Yi-Ying Wu et al. Open Biology
- Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling
- (2019) Dario Pacitti et al. Frontiers in Cellular Neuroscience
- β-Glucocerebrosidase Modulators Promote Dimerization of β-Glucocerebrosidase and Reveal an Allosteric Binding Site
- (2018) Jianbin Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Fetal gene therapy for neurodegenerative disease of infants
- (2018) Giulia Massaro et al. NATURE MEDICINE
- Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease
- (2018) Caleb Pitcairn et al. NEUROBIOLOGY OF DISEASE
- Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide
- (2018) Friederike Zunke et al. NEURON
- GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers
- (2018) Sangjune Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
- (2018) Rafael Franco et al. Frontiers in Neuroanatomy
- Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity
- (2018) Salema B. Abul Khair et al. Frontiers in Neuroscience
- D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
- (2018) Donghoon Kim et al. Acta Neuropathologica Communications
- Exploring genetic modifiers of Gaucher disease: The next horizon
- (2018) Brad A. Davidson et al. HUMAN MUTATION
- Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
- (2018) Anna Lisa Gündner et al. NEUROBIOLOGY OF DISEASE
- Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
- (2018) Michaela E. Johnson et al. TRENDS IN NEUROSCIENCES
- Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
- (2018) Maria Nguyen et al. TRENDS IN NEUROSCIENCES
- Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering
- (2018) Martijn F. Hoes et al. Stem Cells Translational Medicine
- Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy
- (2018) Giacomo Monzio Compagnoni et al. Stem Cell Reports
- Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
- (2018) Sylvain Perriot et al. Stem Cell Reports
- The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase
- (2018) Cathrine K. Fog et al. EBioMedicine
- Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons
- (2017) Sabrina M Heman-Ackah et al. HUMAN MOLECULAR GENETICS
- Gaucher disease: Progress and ongoing challenges
- (2017) Pramod K. Mistry et al. MOLECULAR GENETICS AND METABOLISM
- Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
- (2017) Nahid Tayebi et al. MOLECULAR GENETICS AND METABOLISM
- The use of brain organoids to investigate neural development and disease
- (2017) Elizabeth Di Lullo et al. NATURE REVIEWS NEUROSCIENCE
- Using induced pluripotent stem cells derived neurons to model brain diseases
- (2017) CindyE McKinney Neural Regeneration Research
- The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
- (2017) KerriJ Kinghorn et al. Neural Regeneration Research
- Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells
- (2017) Steven A. Sloan et al. NEURON
- The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
- (2017) Elma Aflaki et al. NEURON
- TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation
- (2017) Sarah Jinn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease
- (2017) Georgia Kouroupi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells
- (2017) Ping Wang et al. Molecular Autism
- Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation
- (2017) Ola Awad et al. Stem Cell Reports
- Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein
- (2017) Anna-Lena Hallmann et al. Scientific Reports
- Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice
- (2016) Anna Migdalska-Richards et al. ANNALS OF NEUROLOGY
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases
- (2016) André R. A. Marques et al. JOURNAL OF LIPID RESEARCH
- The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease
- (2016) Matthew J. Benskey et al. JOURNAL OF NEUROCHEMISTRY
- A New Glucocerebrosidase Chaperone Reduces -Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
- (2016) E. Aflaki et al. JOURNAL OF NEUROSCIENCE
- Activation of -Glucocerebrosidase Reduces Pathological -Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
- (2016) J. R. Mazzulli et al. JOURNAL OF NEUROSCIENCE
- Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis
- (2016) Su Min Lim et al. Molecular Neurodegeneration
- Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease
- (2016) Yvette C. Wong et al. MOVEMENT DISORDERS
- Mitochondrial dysfunction associated with glucocerebrosidase deficiency
- (2016) Matthew E. Gegg et al. NEUROBIOLOGY OF DISEASE
- Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
- (2016) Olga Momcilovic et al. PLoS One
- ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
- (2016) Hugo J.R. Fernandes et al. Stem Cell Reports
- Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
- (2015) Emily M. Rocha et al. ANTIOXIDANTS & REDOX SIGNALING
- Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
- (2015) Ziv Gan-Or et al. Autophagy
- Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients withMAPTmutations
- (2015) Mariangela Iovino et al. BRAIN
- Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1
- (2015) Pramod K. Mistry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genes associated with Parkinson's disease: regulation of autophagy and beyond
- (2015) Alexandra Beilina et al. JOURNAL OF NEUROCHEMISTRY
- The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease
- (2015) Z. Gan-Or et al. JOURNAL OF NEUROLOGY
- The clinical management of type 2 Gaucher disease
- (2015) Karin Weiss et al. MOLECULAR GENETICS AND METABOLISM
- Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells
- (2015) Melissa C. Wren et al. Molecular Neurodegeneration
- Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
- (2015) Giancarlo Parenti et al. MOLECULAR THERAPY
- No evidence for substrate accumulation in Parkinson brains withGBAmutations
- (2015) Matthew E. Gegg et al. MOVEMENT DISORDERS
- Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson’s Disease
- (2015) James M. Gruschus PLoS One
- Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease
- (2015) Mario de la Mata et al. Scientific Reports
- Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein
- (2015) Norihito Uemura et al. PLoS Genetics
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- Histone Acetyltransferase p300 Mediates Histone Acetylation of PS1 and BACE1 in a Cellular Model of Alzheimer's Disease
- (2014) Xi Lu et al. PLoS One
- LIMP-2 expression is critical for -glucocerebrosidase activity and -synuclein clearance
- (2014) M. Rothaug et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage Models of Gaucher Disease for Evaluating Disease Pathogenesis and Candidate Drugs
- (2014) E. Aflaki et al. Science Translational Medicine
- The Biogenesis of Lysosomes and Lysosome-Related Organelles
- (2014) J. P. Luzio et al. Cold Spring Harbor Perspectives in Biology
- iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis
- (2014) David C. Schöndorf et al. Nature Communications
- Transgenic mice expressing human glucocerebrosidase variants: Utility for the study of Gaucher disease
- (2013) Angela Sanders et al. BLOOD CELLS MOLECULES AND DISEASES
- Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease
- (2013) Laura D. Osellame et al. Cell Metabolism
- Cerebral organoids model human brain development and microcephaly
- (2013) Madeline A. Lancaster et al. NATURE
- Unfolded protein response in Gaucher disease: from human to Drosophila
- (2013) Gali Maor et al. Orphanet Journal of Rare Diseases
- Expression of Human Gaucher Disease Gene GBA Generates Neurodevelopmental Defects and ER Stress in Drosophila Eye
- (2013) Takahiro Suzuki et al. PLoS One
- Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
- (2013) C. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones
- (2013) C. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease
- (2013) Sudhakar Raja Subramaniam et al. PROGRESS IN NEUROBIOLOGY
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
- (2012) Carmine Settembre et al. EMBO JOURNAL
- Accumulation of Toxic -Synuclein Oligomer within Endoplasmic Reticulum Occurs in -Synucleinopathy In Vivo
- (2012) E. Colla et al. JOURNAL OF NEUROSCIENCE
- Endoplasmic Reticulum Stress Is Important for the Manifestations of -Synucleinopathy In Vivo
- (2012) E. Colla et al. JOURNAL OF NEUROSCIENCE
- The role of saposin C in Gaucher disease
- (2012) Rafael J. Tamargo et al. MOLECULAR GENETICS AND METABOLISM
- The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
- (2012) Raquel Duran et al. MOVEMENT DISORDERS
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- A Predictable Worm: Application of Caenorhabditis elegans for Mechanistic Investigation of Movement Disorders
- (2012) Paige M. Dexter et al. Neurotherapeutics
- Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
- (2012) L. M. Panicker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Animal models for Gaucher disease research
- (2011) T. Farfel-Becker et al. Disease Models & Mechanisms
- An “Exacerbate-reverse” Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C Disease
- (2011) Andrew B. Munkacsi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ex Vivoandin VivoEffects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
- (2011) Ying Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
- (2011) Thai Leong Yap et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease
- (2011) Ziv Gan-Or et al. NEUROGENETICS
- The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
- (2011) William Benko et al. PLoS One
- Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease
- (2011) J. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts
- (2011) N. H. Pipalia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CNS expression of glucocerebrosidase corrects -synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
- (2011) S. P. Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type 2 Gaucher disease: Phenotypic variation and genotypic heterogeneity
- (2010) N. Gupta et al. BLOOD CELLS MOLECULES AND DISEASES
- A monozygotic twin pair with highly discordant Gaucher phenotypes
- (2010) M. Biegstraaten et al. BLOOD CELLS MOLECULES AND DISEASES
- The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
- (2010) Barry Rosenbloom et al. BLOOD CELLS MOLECULES AND DISEASES
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
- (2010) Richie Khanna et al. FEBS Journal
- Lysosomal Degradation of α-Synucleinin Vivo
- (2010) Sally K. Mak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The risk of Parkinson’s disease in type 1 Gaucher disease
- (2010) Gilberto Bultron et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
- (2009) Tamar H. Taddei et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases
- (2009) Latha Devi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
- (2009) Amy B. Manning-Boğ et al. NEUROTOXICOLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy Using Adeno-Associated Virus Vectors
- (2008) S. Daya et al. CLINICAL MICROBIOLOGY REVIEWS
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
- (2008) Kathleen S. Hruska et al. HUMAN MUTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started